...
首页> 外文期刊>Memórias do Instituto Oswaldo Cruz >Candidate gene analysis of ocular toxoplasmosis in Brazil: evidence for a role for toll-like receptor 9 (TLR9)
【24h】

Candidate gene analysis of ocular toxoplasmosis in Brazil: evidence for a role for toll-like receptor 9 (TLR9)

机译:巴西眼弓形虫病的候选基因分析:Toll样受体9(TLR9)作用的证据

获取原文
           

摘要

Toxoplasma gondii infection is an important mediator of ocular disease in Brazil more frequently than reported from elsewhere. Infection and pathology are characterized by a strong proinflammatory response which in mice is triggered by interaction of the parasite with the toll-like receptor (TLR)/MyD88 pathway. A powerful way to identify the role of TLRs in humans is to determine whether polymorphisms at these loci influence susceptibility to T. gondii-mediated pathologies. Here we report on a small family-based study (60 families; 68 affected offspring) undertaken in Brazil which was powered for large effect sizes using single nucleotide polymorphisms with minor alleles frequencies > 0.3. Of markers in TLR2, TLR5 and TLR9 that met these criteria, we found an association Family Based Association Tests [(FBAT) Z score = 4.232; p = 1.5 x 10-5; p corrected = 1.2 x 10-4] between the C allele (frequency = 0.424; odds ratio = 7; 95% confidence interval 1.6-30.8) of rs352140 at TLR9 and toxoplasmic retinochoroiditis in Brazil. This supports the hypothesis that direct interaction between T. gondii and TLR9 may trigger proinflammatory responses that lead to severe pathologies such as the ocular disease that is associated with this infection in Brazil.
机译:弓形虫感染是巴西眼病的重要介体,发病频率高于其他地方。感染和病理学的特征是强烈的促炎反应,在小鼠中,该寄生虫与通行费样受体(TLR)/ MyD88途径相互作用会触发这种反应。鉴定TLR在人类中的作用的有效方法是确定这些位点的多态性是否影响对弓形虫介导的病理的易感性。在这里,我们报告了在巴西进行的一项基于家庭的小型研究(60个家庭; 68个受影响的后代),该研究使用单等位基因频率大于0.3的单核苷酸多态性,获得了较大的效应量。在满足这些标准的TLR2,TLR5和TLR9中的标记中,我们发现了一个基于家庭的关联测试[[FBAT)Z评分= 4.232; p = 1.5 x 10-5; p校正后= rs352140的C等位基因(频率= 0.424;比值比= 7; 95%置信区间1.6-30.8)在TLR9与巴西弓形体视网膜脉络膜炎之间(p = 1.2 x 10-4)。这支持以下假说:弓形虫和TLR9之间的直接相互作用可能会触发促炎反应,从而导致严重的疾病,例如与巴西感染相关的眼部疾病。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号